Trial intelligence / Profile preview

Phase 3 study of ethinyl estradiol + gestodene transdermal contraceptive patch

2008-004214-27Phase 3Completed

Sponsor
Bayer
Start
Nov 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of ethinyl estradiol and gestodene in contraception, sponsored by Bayer. Primary endpoints: Occurrence of pregnancy, Pearl Index and 1 more. Started Nov 2008; status: completed.

02

Drugs

ethinyl estradiolgestodene
03

Conditions

contraception

Beyond the preview

Go deeper on 2008-004214-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-004214-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call